[Federal Register Volume 61, Number 173 (Thursday, September 5, 1996)]
[Notices]
[Page 46827]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-22631]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE
Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.43(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on May 13, 1996, Noramco of 
Delaware, Inc., Division of McNeilab, Inc., 500 Old Swedes Landing 
Road, Wilmington, Delaware 19801, made application, which was received 
for processing on June 27, 1996, to the Drug Enforcement Administration 
(DEA) for registration as a bulk manufacturer of the basic classes of 
controlled substances listed below:

                                                                        
                           Drug                               Schedule  
                                                                        
Codeine (9050)............................................           II 
Oxycodone (9143)..........................................           II 
Hydrocodone (9193)........................................           II 
Morphine (9300)...........................................           II 
Thebaine (9333)...........................................           II 
Fentanyl (9801)...........................................           II 
                                                                        

    The firm plans to manufacture the listed controlled substances for 
distribution to its customers as bulk product.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the above application.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, D.C. 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than November 4, 1996.

    Dated: August 21, 1996.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 96-22631 Filed 9-4-96; 8:45 am]
BILLING CODE 4410-09-M